Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia

Chabner, 1973, Deamination of 5-azacytidine by a human leukemia cell deaminase, Biochem. Pharmacol., 22, 2763, 10.1016/0006-2952(73)90137-8 Chu, 1968, The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y), Biochem. Pharmacol., 17, 753, 10.1016/0006-2952(68)90012-9 Frei, 1969, Dose schedule and antitumor studies of arabinosyl cytosine, Cancer Res., 29, 1325 Graham, 1970, The effect of 1-β-d-arabinofuranosylcytosine on growth, viability and DNA synthesis of mouse L-cells, Cancer Res., 30, 2627 Ho, 1971, Clinical pharmacology of 1-β-d-arabinofuranosyl cytosine, Clin. Pharmac. exp. Ther., 12, 944, 10.1002/cpt1971126944 Jones, 1980, Cellular differentiation, cytidine analogs, and DNA methylation, Cell, 20, 85, 10.1016/0092-8674(80)90237-8 Lala, 1976, Effects of tumor bearing on the dynamics of host hemopoietic cells, Cancer Chemother. Rep., 60, 1781 Lelkin, 1968, Varying prednisone dosage in remission induction of previously untreated childhood leukemia, Cancer, 21, 346, 10.1002/1097-0142(196803)21:3<346::AID-CNCR2820210303>3.0.CO;2-Y Momparler, 1977, Estimation of cell cycle parameters of clonogenic leukemic cells in vivo using chemotherapeutic agents, 843 Momparler, 1979, Pharmacology of 5-aza-2′-deoxycytidine, 33 Momparler, 1979, Kinetics of phosphorylation of 5-aza-2′-deoxycytidine by deoxycytidine kinase, Biochem. Pharmacol., 28, 1443, 10.1016/0006-2952(79)90454-4 Momparler, 1968, Mammalian deoxynucleoside kinases. I. Deoxycytidine kinase: purification, properties, and kinetic studies with cytosine arabinoside, J. biol. Chem., 243, 4398 Momparler, 1978, Effect of intravenous infusion of 5-aza-2′-deoxycytidine on survival time of mice with L1210 leukemia, Cancer Res., 38, 2673 Momparler, 1977, In vitro cytotoxic and biochemical effects of 5-aza-2′-deoxycytidine, Cancer Res., 37, 1636 Momparler, 1972, Enzymatic estimation and metabolism of 1-β-d-arabinofuranosylcytosine in man, Cancer Res., 32, 408 Momparler, 1979, Synergistic action of 5-aza-2′-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells, Cancer Res., 39, 3822 Pliml, 1964, Synthesis of 2-deoxy-d-ribofuranosyl-5-azacytosine, Colln Czech. chem. Commun., 29, 2576, 10.1135/cccc19642576 Sorm, 1968, Effect of 5-aza-2′-deoxycytidine against leukemic and hemopoietic tissues in AKR mice, Neoplasma, 15, 339 Schein, 1977, Preclinical toxicology of anticancer agents, Cancer Res., 37, 1934 Vesely, 1977, Incorporation of a potent antileukemic agent, 5-aza-2′-deoxycytidine, into DNA of leukemic cells from leukemic mice, Cancer Res., 37, 3684 Vesely, 1970, Association of decreased uridine and deoxycytidine kinase with enhanced RNA and DNA polymerase in mouse leukemic cells resistant to 5-azacytidine and 5-aza-2′-deoxycytidine, Cancer Res., 30, 2180 Yataganas, 1974, Microfluorimetric evaluation of cell kinetics with 1-β-d-arabinofuranoxylcytosine, Cancer Res., 34, 2795 Young, 1968, The action of arabinosylcytosine on synchronously growing populations of mammalian cells, Biochem. Biophys. Res. Commun., 32, 23, 10.1016/0006-291X(68)90420-8